BioSpace News Archive

Larimar Therapeutics, Inc., a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, announced that David Bettoun, PhD, Vice President Discovery & Non-Clinical R&D of Larimar, will be giving an oral presentation at the World Orphan Drug Congress USA 2021, taking place on August 25-27 at the Gaylord National Resort & Convention Center in Oxon Hill, Maryland.

Seqirus today announced plans to accelerate the development of its next generation of messenger RNA (mRNA) vaccine technology

Empower Therapeutics Inc., a Baltimore -based startup, has secured worldwide, exclusive rights to a simple, reliable brainwave biomarker for pain sensitivity.

Esker Therapeutics today announced the appointment of Jeff Douglas as vice president of clinical operations.

Biocept’s CNSide Assay Identifies Tumor Cells and Actionable Treatment Biomarkers from Cerebrospinal Fluid in Patients with Metastatic Non-Small Cell Lung Cancer

Simulations Plus, Inc. today announced that it has received the second phase of experimental results from a collaborative research agreement it entered with a large pharmaceutical company in mid-2020 to evaluate the new module.

Napo Pharmaceuticals, Inc. (Napo), the wholly owned US subsidiary of Jaguar Health, Inc. (NASDAQ:JAGX), today announced the signing of a license agreement with Napo’s Italian subsidiary, Napo EU S.p.A.

Thomas Inventory Management Solutions will help scientific customers sidestep common operational and logistical pain points.

180 Life Sciences Corp. today announced that it has entered into securities purchase agreements with certain institutional investors to raise approximately $15.0 million through the private placement of 2,500,000 shares of its common stock

Former Assistant Secretary of Defense for Nuclear, Chemical & Biological Defense Programs, Andrew C. Weber Expert on Chemical and Biological Weapons, Dr. Gregory Koblentz has joined Advisory Board.